Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One

Download
Download White Paper
Related Solutions
Clinical
CMC Strategy & Development
Discovery Sciences
Medical Writing
Regulatory Strategy
Scientific, Regulatory & Quality
Technical Operations & Delivery Infrastructure
Biologics
Cell & Gene Therapy
Discovery
Emerging & Early-Stage Biotech
For Private Equity & Investors
Mid-Sized to Large Enterprise Biopharma
Preclinical
Small Molecule
Related Resources
All Resources

white-paper
Navigating Harmonized Tariff Schedule of the United States Classification: A Strategic Guide for Small Biotechs Importing Investigational Medicinal Products
Read More

post
Why Development Plans Fail in the Sequencing, Not the Science
Read More

infographic
The Roadmap Swimlane Framework
Read More

post
What a Board-Ready Roadmap Actually Looks Like
Read More
Let's move from science to success.
Let’s Talk
